Previous 10 | Next 10 |
home / stock / mkgaf / mkgaf news
Summary Using Procter & Gamble and Unilever as examples, I will show how a close look at their cash flow statements brings to light fundamental differences between the two consumer staples giants. The article provides a good understanding of the key items on a cash flow statem...
Summary Sartorius stock has corrected by 55% over the last 12 months, visibly underperforming its peers and the pharmaceutical companies. Despite this, we rate the shares as neutral and stay on the sidelines until order visibility improves. We believe that the business will co...
Merck KGaA's ( OTCPK:MKGAF ) ( OTCPK:MKKGY ) on Oct. 6 reaffirmed its growth objectives noting that up until 2025, it expects to grow sales organically by at least 6% on average per year, equivalent to an increase of more than €1B annually. The German giant added ...
Merck KGaA ( OTCPK:MKKGY ) has brokered a licensing agreement with Nerviano Medical Sciences gaining access to NMS-293, a next-generation highly selective and brain-penetrant PARP1 inhibitor. NMS-293 is currently in phase 1 as monotherapy for BRCA-mediated tumors and in co...
MERCK Kommanditgesellschaft auf Aktien (MKGAF) Q2 2022 Results Conference Call August 04, 2022 08:00 AM ET Company Participants Constantin Fest - Head, IR Belen Garijo - Group, CEO Marcus Kuhnert - Group CFO Matthias Heinzel - CEO, Life Science Peter Guen...
The following slide deck was published by MERCK Kommanditgesellschaft auf Aktien in conjunction with their 2022 Q2 earnings call. For further details see: MERCK Kommanditgesellschaft auf Aktien 2022 Q2 - Results - Earnings Call Presentation
Merck KGaA's ( OTCPK:MKGAF ) ( OTCPK:MKKGY ) Q2 revenue was driven by its main three business divisions and the company raised its FY22 outlook. Q2 GAAP EPS rose +17.9% to €2.64, while Group net sales grew +14.3% Y/Y to €5.57B. EBITDA pre incr...
MERCK Kommanditgesellschaft auf Aktien press release ( OTCPK:MKGAF ): Q2 Non-GAAP EPS of €2.64. Revenue of €5.57B (+14.4% Y/Y). For further details see: MERCK Kommanditgesellschaft auf Aktien Non-GAAP EPS of €2.64, revenue of €5....
Micron to Select Athinia™ for Pioneering Data Collaboration PR Newswire A long-term, strategic, enterprise-level technology collaboration aims to further increase production efficiencies and reduce costs for Micron and its suppliers CAMBRIDGE, Mass...
Merck Korea, a unit of Germany-based Merck KGaA (OTCPK:MKGAF) (OTCPK:MKKGY), signed an agreement with Seoul-based Standigm for artificial intelligence (AI) based drug discovery research. Under the Memorandum of Understanding (MOU), Standigm will accelerate its drug discove...
News, Short Squeeze, Breakout and More Instantly...
Merck Kgaa Company Name:
MKGAF Stock Symbol:
OTCMKTS Market:
Bank of Georgia Group Plc (BDGSF) is expected to report for Q1 2024 iCad Inc. (ICAD) is expected to report for Q1 2024 Yasheng Group (HERB) is expected to report for Q1 2024 Bit Digital Inc. (BTBT) is expected to report $0.01 for Q1 2024 Estrella Immunopharma Inc. (ESLA) is expect...
Apartment Investment and Management Company (AIV) is expected to report for Q1 2024 Shopify Inc. Class A Subordinate (SHOP) is expected to report $0.08 for Q1 2024 Beyond Meat Inc. (BYND) is expected to report $-0.68 for Q1 2024 Instructure Holdings Inc. (INST) is expected to report $...
Gevo Inc. (GEVO) is expected to report $-0.05 for Q4 2023 Harvard Bioscience Inc. (HBIO) is expected to report $0.03 for Q4 2023 QuantaSing Group Limited (QSG) is expected to report $0.11 for Q2 2024 DFI Retail Group Holdings Limited ADR (DFIHY) is expected to report for quarter end 2...